Animals
Disease Models, Animal
Docosahexaenoic Acids
/ chemistry
Encephalitis
/ drug therapy
Ethanolamines
/ pharmacology
Hippocampus
/ drug effects
Long-Term Potentiation
Male
Memory Disorders
/ drug therapy
Mice
Mice, Inbred C57BL
Microglia
/ drug effects
Neuronal Plasticity
/ drug effects
Neurons
/ drug effects
DHEA
N-docosahexanoylethanolamine
cytokines
dendrites
long-term potentiation
microglia
neurogenesis
neuroinflammation
synaptamide
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
19 Dec 2020
19 Dec 2020
Historique:
received:
28
11
2020
revised:
14
12
2020
accepted:
16
12
2020
entrez:
23
12
2020
pubmed:
24
12
2020
medline:
2
4
2021
Statut:
epublish
Résumé
Chronic neuroinflammation is a common pathogenetic link in the development of various neurological and neurodegenerative diseases. Thus, a detailed study of neuroinflammation and the development of drugs that reduce or eliminate the negative effect of neuroinflammation on cognitive processes are among the top priorities of modern neurobiology.
Identifiants
pubmed: 33352646
pii: ijms21249703
doi: 10.3390/ijms21249703
pmc: PMC7767308
pii:
doi:
Substances chimiques
Ethanolamines
0
synaptamide
0
Docosahexaenoic Acids
25167-62-8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Russian Science Foundation
ID : 20-75-00012
Références
Br J Pharmacol. 2004 Mar;141(5):775-85
pubmed: 14757702
Biol Open. 2015 Nov 06;4(12):1660-70
pubmed: 26545965
J Food Sci Technol. 2016 Mar;53(3):1722-6
pubmed: 27570298
J Neurosci. 2002 Jan 15;22(2):486-92
pubmed: 11784794
Nat Protoc. 2006;1(3):1306-11
pubmed: 17406415
Mol Neurodegener. 2009 Nov 16;4:47
pubmed: 19917131
J Clin Psychopharmacol. 2016 Dec;36(6):691-703
pubmed: 27811555
Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):114-20
pubmed: 21810478
J Thromb Haemost. 2017 Mar;15(3):565-574
pubmed: 28005311
Learn Mem. 2009 Jan 29;16(2):147-54
pubmed: 19181621
Eur J Pharmacol. 2007 Oct 31;572(2-3):160-70
pubmed: 17662268
J Neuroinflammation. 2019 May 18;16(1):106
pubmed: 31103036
Neuron. 2014 Oct 22;84(2):347-54
pubmed: 25308331
Brain Behav Immun. 2015 Feb;44:159-66
pubmed: 25451612
Front Pharmacol. 2014 Jan 02;4:169
pubmed: 24427139
Brain Behav Immun. 2008 Mar;22(3):301-11
pubmed: 17951027
J Neuroinflammation. 2019 Nov 15;16(1):225
pubmed: 31730008
Neuroscience. 2006;139(3):991-7
pubmed: 16527422
Mol Aspects Med. 2018 Dec;64:34-44
pubmed: 29572109
J Neurosci. 2020 Mar 25;40(13):2593-2605
pubmed: 32047054
Neuroscience. 2012 Dec 27;227:211-22
pubmed: 23041513
J Neuroinflammation. 2015 Jan 09;12:3
pubmed: 25573647
Nat Rev Neurosci. 2011 Jan;12(1):17-30
pubmed: 21170072
Alzheimers Dement. 2010 Nov;6(6):456-64
pubmed: 20434961
J Neurosci. 2003 Mar 1;23(5):1605-11
pubmed: 12629164
J Neuroinflammation. 2004 Jul 7;1(1):12
pubmed: 15285803
Eur J Pharmacol. 2001 Jun 22;422(1-3):69-76
pubmed: 11430915
J Neurosci. 2001 Sep 1;21(17):6480-91
pubmed: 11517237
Prostaglandins Leukot Essent Fatty Acids. 2013 Jan;88(1):121-5
pubmed: 22959887
Neuroscience. 2015 Dec 17;311:231-42
pubmed: 26480811
Brain Res. 2004 Jul 23;1015(1-2):145-53
pubmed: 15223378
Neuropharmacology. 2004 Dec;47(7):945-60
pubmed: 15555630
J Neurosci. 1997 May 1;17(9):2939-46
pubmed: 9096130
Brain Res. 2002 Oct 11;952(1):78-85
pubmed: 12363407
J Alzheimers Dis. 2010;20 Suppl 2:S369-79
pubmed: 20463396
Brain Behav Immun. 2012 Aug;26(6):959-71
pubmed: 22609298
Mol Psychiatry. 2010 Apr;15(4):384-92
pubmed: 19488045
Neurobiol Aging. 2012 Mar;33(3):603-616.e3
pubmed: 20471138
J Cell Sci. 2013 Sep 15;126(Pt 18):4208-19
pubmed: 23843621
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6402-6
pubmed: 11353819
Eur J Neurosci. 2005 Jan;21(2):513-21
pubmed: 15673450
Front Mol Neurosci. 2016 Jan 05;8:78
pubmed: 26778955
Nutrients. 2010 Mar;2(3):355-74
pubmed: 22254027
J Neuroinflammation. 2016 Nov 3;13(1):283
pubmed: 27809864
J Neurosci. 2002 Feb 1;22(3):854-62
pubmed: 11826115
Nature. 2012 Mar 22;484(7394):381-5
pubmed: 22441246
FASEB J. 2010 Apr;24(4):1043-55
pubmed: 19906677
J Physiol. 2007 May 15;581(Pt 1):107-28
pubmed: 17303642
J Neurochem. 1999 Feb;72(2):652-60
pubmed: 9930737
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6034-E6043
pubmed: 28687674
Mar Drugs. 2020 Oct 15;18(10):
pubmed: 33076443
Neurologia. 2012 Jun;27(5):301-10
pubmed: 22217527
Neurosci Lett. 1995 Sep 29;198(2):95-8
pubmed: 8592650
Br J Pharmacol. 2013 Jun;169(4):772-83
pubmed: 23088259
J Neurochem. 2013 Jun;125(6):897-908
pubmed: 23578284
Brain Res. 1992 Apr 10;577(1):169-74
pubmed: 1521143
J Neurosci. 2007 Sep 26;27(39):10445-55
pubmed: 17898216
J Neurochem. 2013 Jun;125(6):869-84
pubmed: 23570577
Neurobiol Aging. 2007 May;28(5):639-47
pubmed: 16697488
Neuron. 2014 Jul 2;83(1):189-201
pubmed: 24991962
Psychopharmacology (Berl). 2016 Mar;233(5):905-16
pubmed: 26645224
Exp Gerontol. 1998 Nov-Dec;33(7-8):813-26
pubmed: 9951625
Biomed Res. 2017;38(3):183-188
pubmed: 28637953
Chem Phys Lipids. 2018 Jan;210:90-97
pubmed: 29126855
Front Immunol. 2016 Mar 31;7:123
pubmed: 27065076
J Lipid Res. 2010 Jun;51(6):1416-23
pubmed: 20071693
J Neuroimmunol. 1996 Dec;71(1-2):11-8
pubmed: 8982097
J Anat. 1953 Oct;87(4):387-406
pubmed: 13117757
J Neurochem. 2013 Nov;127(3):378-93
pubmed: 23919613
Biomed Res Int. 2015;2015:854359
pubmed: 25705693
J Neurochem. 2009 Oct;111(2):510-21
pubmed: 19682204
J Neuroinflammation. 2016 Nov 4;13(1):284
pubmed: 27809877